Skip to main content
SpringerLink
Log in

Cyclosporin A treatment for Japanese patients with severe adult-onset Still’s disease

  • Original Article
  • Published:
Modern Rheumatology

Abstract

For over 10 years there have been no clinical studies about adult-onset Still’s disease (AOSD) in Japan. We aimed to investigate recent clinical features and treatment of AOSD and to evaluate the efficacy of cyclosporin A (CyA) in the treatment of AOSD. The data from 34 patients with AOSD who were admitted to our hospital between 1994 and 2007 were analyzed retrospectively. Of several immunosuppressive agents, the efficacy of CyA given to seven patients was precisely evaluated. Clinical features observed in this study did not differ from those in our previous study, and serum ferritin levels were elevated in all the patients. Among immunosuppressive agents CyA, used concomitantly with corticosteroids (CS) for seven patients with severe AOSD, proved to be very effective. The disease was led to remission promptly by CyA in six patients, and all the patients except one experienced no recurrence. These results suggest that CyA can be one of the potent candidates to be used next to CS for patients with AOSD that is resistant to CS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Reginato A. Adult onset Still’s disease: experience in 23 patients and literature review with emphasis on organ failure. Sem Arthritis Rheum. 1987;17:39–57.

    Article  CAS  Google Scholar 

  2. Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salusinsky SM et al. Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine. 1991;70:118–36.

    Article  PubMed  CAS  Google Scholar 

  3. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol. 1992;19:424–30.

    PubMed  CAS  Google Scholar 

  4. Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still’s disease. Arthritis Rheum. 2001;44:550–60.

    Article  PubMed  CAS  Google Scholar 

  5. Choi JH, Suh CH, Lee JM, Suh YJ, Lee SK, Kim SS et al. Serum cytokine profiles inpatients with adult onset Still’s disease. J Rheumatol. 2003;30:2422–7.

    PubMed  CAS  Google Scholar 

  6. Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still’s disease. J Rheumatol. 2004;31:2189–98.

    PubMed  CAS  Google Scholar 

  7. Ohta A, Yamaguchi M, Tsunematsu T, Kasukawa R, Mizushima H, Kashiwagi H et al. Adult Still’s disease: a multicenter survey of Japanese patients. J Rheumatol. 1990;17:1058–63.

    PubMed  CAS  Google Scholar 

  8. Kokkins A, Iliopoulos A, Greka P, Efthymiou A, Katsilambros N, Sfikakis PP. Successful treatment of refractory adult-onset Still’s disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol. 2004;23:45–9.

    Article  Google Scholar 

  9. Hushi ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM et al. Etanercept in the treatment of adult patients with Still’s disease. Arthritis Rheum. 2002;46:1171–6.

    Article  CAS  Google Scholar 

  10. Iwamoto M, Nara H, Hirata D, Minota S, Nishimoto N, Yoshizaki K. Humanized monoclonal anti-interleukin 6 receptor antibody for treatment of intractable adult-onset Still’s disease. Arthritis Rheum. 2002;46:3388–9.

    Article  PubMed  CAS  Google Scholar 

  11. Fautrel B, Zing E, Golmard JL, Moel GL, Bissery A, Rioux C et al. Proposal for a new set of classification criteria for adult-onset Still disease. Medicine (Baltimore) 2002;81:194–200.

    Google Scholar 

  12. Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still’s disease. Ann Rheum Dis. 2006;65:564–72.

    Article  PubMed  CAS  Google Scholar 

  13. Dougados M, Awada H, Amor B. Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. Ann Rheum Dis. 1988;47:127–33.

    Article  PubMed  CAS  Google Scholar 

  14. Ostensen M, Hoyeraal HM, Kass E. Tolerance of cyclosporine A in children with refractory juvenile rheumatoid arthritis. J Rheumatol. 1988;15:1536–8.

    PubMed  CAS  Google Scholar 

  15. Marchesoni A, Ceravolo GP, Battafarano N, Rossetti A, Tosi S, Fantini F. Cyclosporin A in the treatment of adult onset Still’s disease. J Rheumatol. 1997;24:1582–7.

    PubMed  CAS  Google Scholar 

  16. Singh S, Samant R, Joshi VR. Adult onset Still’s disease: a study of 14 cases. Clin Rheumatol. 2008;27:35–9.

    Article  PubMed  CAS  Google Scholar 

  17. Park JH, Bae JH, Choi YS, Lee HS, Jun JB, Jung S et al. Adult onset Still’s disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A. J Korean Med Sci. 2004;19:137–41.

    Article  PubMed  Google Scholar 

  18. Kam S, Andrew C, Karen R. Cyclosporin A in the treatment of adult Still’s disease. J Rheumatol. 1995;22:1391–2.

    Google Scholar 

  19. McCune WJ, Marder W, Riskalla M. Immunosuppressive drug therapy. In: Wallace DJ, Hahn BH, editors. Dubois’ lupus erythematosus. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 1198–224.

    Google Scholar 

  20. Maillefert JF, Duchamp O, Solary E, Genne P, Tavernier C. Effects of cyclosporine at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells. Ann Rheum Dis. 2000;59:146–8.

    Article  PubMed  CAS  Google Scholar 

  21. List AF, Kopecky KJ, Willman CL, Head DR, Slovak ML, Douer D et al. Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase. Blood. 2002;100:1910–2.

    PubMed  CAS  Google Scholar 

  22. Fautrel B, Borget C, Rozenberg S, Meyer O, Loet XL, Masson C et al. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still’s disease. J Rheumatol. 1999;26:373–8.

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest statement

This article does not contribute to any conflict of interest.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan

    Mio Mitamura, Yoshifumi Tada, Syuichi Koarada, Hisako Inoue, Rie Suematsu & Kohei Nagasawa

  2. Department of Nursing, Faculty of Medicine, Saga University, Saga, Japan

    Akihide Ohta

Authors
  1. Mio Mitamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshifumi Tada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Syuichi Koarada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hisako Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rie Suematsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Akihide Ohta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kohei Nagasawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mio Mitamura.

About this article

Cite this article

Mitamura, M., Tada, Y., Koarada, S. et al. Cyclosporin A treatment for Japanese patients with severe adult-onset Still’s disease. Mod Rheumatol 19, 57–63 (2009). https://doi.org/10.1007/s10165-008-0126-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-008-0126-0

Keywords

Search

Navigation